Dr. Taha Alrifai, MD
- Medicare services, 2024
- 1,009
- Medicare patients, 2024
- 337
- Part D claims, 2024
- 574
- Publications
- 15
- Hospital affiliations
- 3
- Practice address
- 1653 West Congress Parkway, Chicago, IL 60612
- Practice phone
- Call (312) 942-5000
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Alrifai's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Taha Alrifai is a hematologist and oncologist in Chicago, Illinois
Dr. Alrifai practices at Rush University Medical Center in Chicago, Illinois, part of Rush System for Health.
Dr. Alrifai's NPI, 1023463932, was assigned on April 28, 2016. Dr. Alrifai holds Illinois license 036147384.
- NPI
- 1023463932NPI Registry (opens in a new tab)
- Medicare PAC ID
- 4880929199
- NPI enumeration date
- April 28, 2016
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Practice phone
- (312) 942-5000
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 38
- Medical school graduation
- 2014
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Taha Alrifai practices at Rush University Medical Center in Chicago, Illinois
Dr. Alrifai's primary practice is Rush University Medical Center, at 1653 West Congress Parkway, Chicago, IL 60612 in Cook County. The practice phone is (312) 942-5000.
- Rush University Medical Center1653 West Congress Parkway, Chicago, IL 60612 · Cook CountyPhone(312) 942-5000
Source: Dmand AI Affiliation Data
Dr. Taha Alrifai is affiliated with 6 sites of care and 4 medical groups
Dr. Alrifai's primary practice is Rush University Medical Center in Chicago, Illinois, part of Rush System for Health. Dr. Alrifai is also affiliated with Advocate Illinois Masonic Medical Center. The medical group on file is Dreyer Medical Clinic (Advocate Medical Group). Dmand AI also links Dr. Alrifai to 1 more hospital, 3 group practices and clinics and 3 medical groups, each named with a free account.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Taha Alrifai's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Alrifai practices, 6 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Rush University Medical Center | Available with a free account |
| +5 more sites and 3 medical groups | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across Rush System for Health and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Taha Alrifai is one of 563 hematologists and oncologists in Illinois
Hematology and oncology is Dr. Alrifai's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Alrifai is board certified in hematology by the American Board of Internal Medicine. Dr. Alrifai is licensed in Illinois.
Specialties and state licenses
- Hematology and oncology, IllinoisPrimary
Hematologists and oncologists near Dr. Alrifai
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Taha Alrifai billed Medicare for 1,009 services in 2024
CMS data shows 1,009 Medicare services from Dr. Alrifai across 9 procedure codes in 2024, for 337 Medicare patients. Medicare paid $94,191 for them.
Dr. Alrifai's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 1742024: 1,009480%
Where Dr. Alrifai's Medicare services took place, 2024
- In an office37938%
- In a facility63062%
Dr. Alrifai compared with the Illinois median for hematologists and oncologists, 2024
- Dr. Alrifai
- Illinois median
- Medicare services
- 1,009vs 1,056Close to median
- Medicare patients
- 337vs 28220% above
- Part D claims
- 397vs 32821% above
Medians across 547 hematologists and oncologists in Illinois with Dmand AI profiles that report each measure.
Dr. Alrifai's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Alrifai?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Alrifai and other hematologists and oncologists in Illinois.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Taha Alrifai treated 337 Medicare patients in 2024, average age 75
CMS counts 337 Medicare patients who saw Dr. Alrifai in 2024. The largest group is 75 to 84, with 147 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 20% are also on Medicaid. Their average risk score is 2.54, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Alrifai's median patient age at 68, with 48% women.
Dr. Alrifai's Medicare patients by age, 2024
Dr. Alrifai's Medicare patients by sex, 2024
- Women18555%
- Men15245%
Chronic conditions among Dr. Alrifai's Medicare patients, 2024
- High blood pressure75%
- High cholesterol75%
- Arthritis56%
- Chronic kidney disease47%
- Diabetes42%
- Ischemic heart disease42%
- Heart failure39%
- Anxiety29%
Share of Medicare patients with each condition. A patient can have several.
Dr. Alrifai's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 68
Patient panel by sex, all payers
- Women48%
- Men51%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Taha Alrifai wrote 574 Medicare Part D claims in 2024
In 2024, Dr. Alrifai wrote 574 Medicare Part D claims for 142 patients. 61% of them were for generic drugs. CMS names the drug for 397 of them, across 16 drugs with 11 or more claims each, at $1,377,413 in total drug cost. In 2018, CMS named 11 claims across 1 drug.
Dr. Alrifai's Part D claims by kind of drug, 2024
- Generic353 claims61%
- Brand-name221 claims39%
Dr. Alrifai's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Alrifai's Part D claims, 2024
- Opioids3%17 of 574 claims
- Antibiotics3%20 of 574 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2018 to 2024
- 2018
- 2024
- Claims for drugs CMS names
- 2018: 112024: 3973509%
Drugs named by CMS: 16 in 2024, 1 in 2018.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Taha Alrifai offers telehealth to Medicare patients
Dr. Alrifai accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Alrifai as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Source: Doctors and Clinicians National Downloadable File (CMS)
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Taha Alrifai has 15 publications on record
Dmand AI links 15 papers to Dr. Alrifai, published from 2016 to 2024. 2019 was the busiest year, with 6. Dr. Alrifai has published most often in BMJ Case Rep. Dr. Alrifai's most frequent co-authors are Reem Md Karmali, MD, Nicole Kelly Yun, MD and Irene Dehghan-Paz, MD.
Dr. Alrifai's papers by year, 2016 to 2024
Dr. Alrifai's most frequent co-authors
- Reem Md Karmali, MD3 shared papers
- Nicole Kelly Yun, MD2 shared papers
- Irene Dehghan-Paz, MD1 shared paper
Recent publications by Dr. Alrifai
See who Dr. Alrifai researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Alrifai works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Taha Alrifai received $368 in industry payments from 2021 to 2023
CMS Open Payments shows 3 general payments to Dr. Alrifai from 1 drug or device company from 2021 to 2023. Food and beverage make up the largest share, 100% of the total. Sanofi and Genzyme US Companies paid the most, $368.
General payments to Dr. Alrifai by program year, 2021 to 2023
Companies that paid Dr. Alrifai the most, 2021 to 2023
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Taha Alrifai is board certified in hematology
- Board certified in hematology
- Board certified in internal medicine
- Board certified in medical oncology
Source: Dmand AI Professional Profile Data
Sources for Dr. Taha Alrifai's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Taha Alrifai
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Taha Alrifai's NPI number?
Dr. Taha Alrifai's NPI number is 1023463932. It was assigned on April 28, 2016, and it is active in the NPI Registry.
What kind of doctor is Dr. Taha Alrifai?
Dr. Taha Alrifai is a hematologist and oncologist in Chicago, Illinois. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Taha Alrifai practice?
Dr. Alrifai practices at 1653 West Congress Parkway, Chicago, IL 60612. Dr. Alrifai's primary practice is Rush University Medical Center in Chicago, Illinois, part of Rush System for Health. Dmand AI also links Dr. Alrifai to 1 hospital, 3 group practices and clinics and 3 medical groups.
What is Dr. Taha Alrifai's office phone number?
The practice phone on file for Dr. Alrifai is (312) 942-5000.
What is Dr. Taha Alrifai's medical license number?
Dr. Alrifai holds Illinois license 036147384.
Which hospitals is Dr. Taha Alrifai affiliated with?
Dr. Alrifai practices at Rush University Medical Center in Chicago, Illinois. Dr. Alrifai is also affiliated with Advocate Illinois Masonic Medical Center. Dmand AI links Dr. Alrifai to 1 more hospital.
What medical group is Dr. Taha Alrifai part of?
Dr. Alrifai is linked to Dreyer Medical Clinic (Advocate Medical Group). Dmand AI links Dr. Alrifai to 3 more medical groups.
Does Dr. Taha Alrifai accept Medicare?
Yes. CMS data shows Dr. Alrifai billed Medicare for 1,009 services in 2024, and Dr. Alrifai accepts Medicare assignment.
Does Dr. Taha Alrifai offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Alrifai as offering telehealth services.
How many Medicare patients does Dr. Taha Alrifai see?
CMS counts 337 Medicare patients who saw Dr. Alrifai in 2024, with an average age of 75.
Show 7 more questionsShow fewer questions
Is Dr. Taha Alrifai board certified?
Yes. Dr. Alrifai is board certified in hematology by the American Board of Internal Medicine.
What services does Dr. Taha Alrifai bill to Medicare?
In 2024, Dr. Alrifai's most billed Medicare services were hospital inpatient care (99233), office visit, established patient (99214) and office visit, established patient (99215).
What drugs does Dr. Taha Alrifai prescribe most?
In 2024 Medicare Part D data, Dr. Alrifai's most prescribed drugs by claims were Eliquis, Acyclovir and Prednisone.
Has Dr. Taha Alrifai received payments from drug or device companies?
CMS Open Payments shows $368 in general payments to Dr. Alrifai from 1 company from 2021 to 2023. The largest total came from Sanofi and Genzyme US Companies.
How long has Dr. Taha Alrifai been practicing?
Dr. Alrifai graduated from medical school in 2014, 12 years ago.
Does Dr. Taha Alrifai do research?
Dmand AI links 15 publications to Dr. Alrifai, published from 2016 to 2024.
Who does Dr. Taha Alrifai publish with?
Dr. Alrifai's most frequent co-authors are Reem Md Karmali, MD (3 shared papers), Nicole Kelly Yun, MD (2 shared papers) and Irene Dehghan-Paz, MD (1 shared paper).
Selling to hematology and oncology practices?
See hematologists and oncologists in Illinois by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card